Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
…, PG Lysko, PJ McKenna, R Feuerstein, JL Gu… - … of Pharmacology and …, 1992 - ASPET
The antioxidant effect of carvedilol, a new vasodilating, beta adrenoceptor blocker was
studied and compared with five other beta blockers. Carvedilol rapidly inhibited Fe(++)-initiated …
studied and compared with five other beta blockers. Carvedilol rapidly inhibited Fe(++)-initiated …
Inhibition of extracellular signal–regulated kinase enhances ischemia/reoxygenation–induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion …
Three major mammalian mitogen-activated protein kinases, extracellular signal–regulated
kinase (ERK), p38, and c-Jun NH 2 -terminal protein kinase (JNK), have been identified in the …
kinase (ERK), p38, and c-Jun NH 2 -terminal protein kinase (JNK), have been identified in the …
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator–activated receptor-γ agonist rosiglitazone
…, PK Narayanan, A Bril, W Jiang, PG Lysko, JL Gu… - Circulation, 2001 - Am Heart Assoc
Background Diabetes is associated with increased risk of mortality as a consequence of
acute myocardial infarction. This study determined whether rosiglitazone (ROSI) could reduce …
acute myocardial infarction. This study determined whether rosiglitazone (ROSI) could reduce …
Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells
X Wang, GZ Feuerstein, JL Gu, PG Lysko, TL Yue - Atherosclerosis, 1995 - Elsevier
Increased expression of cell adhesion molecules is an important pathological event during
the development of atherosclerosis. The smooth muscle cell (SMC) is one of the cell types …
the development of atherosclerosis. The smooth muscle cell (SMC) is one of the cell types …
Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.
…, CP Sung, B Olson, PJ McKenna, JL Gu… - Circulation …, 1994 - Am Heart Assoc
Interleukin-8 (IL-8) is a chemokine produced by a variety of cell types involved in atherogenesis
and is chemotactic for neutrophils and lymphocytes. A recent study has shown that IL-8 …
and is chemotactic for neutrophils and lymphocytes. A recent study has shown that IL-8 …
Activation of peroxisome proliferator–activated receptor-α protects the heart from ischemia/reperfusion injury
T Yue, W Bao, BM Jucker, J Gu, AM Romanic… - Circulation, 2003 - Am Heart Assoc
Background— Peroxisome proliferator–activated receptor-α (PPAR-α) is expressed in the
heart and regulates genes involved in myocardial fatty acid oxidation (FAO). The role of PPAR-…
heart and regulates genes involved in myocardial fatty acid oxidation (FAO). The role of PPAR-…
[HTML][HTML] Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy
TL Yue, JL Gu, C Wang, AA Parsons… - Journal of Biological …, 2000 - ASBMB
The extracellular signal-regulated kinase (ERK) pathway is activated by hypertrophic stimuli
in cardiomyocytes. However, whether ERK plays an essential role or is implicated in all …
in cardiomyocytes. However, whether ERK plays an essential role or is implicated in all …
2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein …
…, X Wang, CS Louden, S Gupta, K Pillarisetti, JL Gu… - Molecular …, 1997 - ASPET
2-Methoxyestradiol (2-ME) is an endogenous metabolite of estradiol-17β and the oral
contraceptive agent 17-ethylestradiol. 2-ME was recently reported to inhibit endothelial cell …
contraceptive agent 17-ethylestradiol. 2-ME was recently reported to inhibit endothelial cell …
Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte …
…, AM Romanic, G Liu, C Louden, JL Gu… - Circulation …, 1998 - Am Heart Assoc
Carvedilol, a new vasodilating β-adrenoceptor antagonist and a potent antioxidant, produces
a high degree of cardioprotection in a variety of experimental models of ischemic cardiac …
a high degree of cardioprotection in a variety of experimental models of ischemic cardiac …
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
Following a similar report on multiple myeloma, Ghione and colleagues report the expected
observation that patients with non-Hodgkin lymphoma (NHL) receiving anti-B cell therapies …
observation that patients with non-Hodgkin lymphoma (NHL) receiving anti-B cell therapies …